cladribine has been researched along with Nervous System Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anwar, MM | 1 |
| Goodin, D | 1 |
| Willoughby, E | 1 |
| Cheson, BD; Foss, FM; Sorensen, JM; Vena, DA | 1 |
2 review(s) available for cladribine and Nervous System Disorders
| Article | Year |
|---|---|
Immunotherapies and COVID-19 related Neurological manifestations: A Comprehensive Review Article.
Topics: Brain; Cladribine; COVID-19; Cytokine Release Syndrome; Cytokines; Glucocorticoids; Headache; Humans; Immunoglobulins, Intravenous; Immunotherapy; Interferon-beta; Interleukin-6; Nervous System Diseases; Pandemics | 2020 |
Neurotoxicity of purine analogs: a review.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Male; Middle Aged; Nervous System; Nervous System Diseases; Pentostatin; Purine Nucleosides; Vidarabine | 1994 |
2 other study(ies) available for cladribine and Nervous System Disorders
| Article | Year |
|---|---|
Multiple Sclerosis: The Big Questions- The MS Forum Workshop.
Topics: Canada; Cladribine; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Nervous System Diseases; Neurology; Societies, Medical | 2011 |
American academy of neurology annual meeting.
Topics: Academies and Institutes; Administration, Oral; Canada; Cladribine; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Nervous System Diseases; Neurology | 2011 |